Indegene Ratios

Indegene Ltd Ratios

The Indegene Ltd Ratios page provides a complete fundamental analysis of Indegene Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Indegene Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Indegene Ltd (NSE: INDGN, BSE: 544172) is currently trading at ₹474.70, with a market capitalization of ₹113.03B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Indegene Ltd remains a key stock for fundamental analysis using Indegene Ltd Ratios.

Indegene Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Indegene Ltd P/E ratio currently stands at 33.97, making it one of the most tracked metrics in Indegene Ltd Ratios.

Historically, the Indegene Ltd P/E ratio has shown strong fluctuations:

• 2024: 33.97
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The rising Indegene Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Indegene Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.30.

Historical P/B trend:

• 2024: 5.30
• 2023: 0
• 2022: 0
• 2021: 0

Indegene Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Indegene Ltd P/S ratio currently stands at 4.87, an important part of Indegene Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.87
• 2023: 0
• 2022: 0
• 2021: 0

The rising Indegene Ltd P/S ratio indicates improved revenue valuation by investors.

Indegene Ltd Price to Cash Flow Ratio (P/CF)

The Indegene Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 28.17.

Historical Indegene Ltd Price to Cash Flow Ratio:

• 2024: 28.17
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 0

The rising Indegene Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Indegene Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Indegene Ltd EV currently stands at ₹122.53B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 122.53B
• 2023: 0
• 2022: 0
• 2021: 0

Indegene Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Indegene Ltd EV/EBITDA ratio is currently 22.80, a key metric in Indegene Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 22.80
• 2023: 0
• 2022: 0
• 2021: 0

Higher Indegene Ltd EV/EBITDA suggests premium valuation.

Indegene Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Indegene Ltd D/E ratio is currently 0.04, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.04
• 2023: 0.34
• 2022: 0.47
• 2021: 0.09

Indegene Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Indegene Ltd ROE currently stands at 20.11%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 20.11
• 2023: 27.01
• 2022: 29.12
• 2021: 30.28

Indegene Ltd demonstrates strong profitability and efficient capital utilization.

Indegene Ltd Ratios Analysis Summary

The Indegene Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Indegene Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Indegene Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.